EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

UK Biobank: Transforming drug discovery and precision medicine

Jelena Bešević, Saredo Said, Reka Nagy, Yalda Jamshidi, Christopher D Whelan, Lauren Carson, Martin K Rutter, Adam J Lewandowski, Mark Effingham, Rory Collins, Ben Lacey iD, Naomi E Allen

British Journal of Pharmacology · 2026

DOI: 10.1111/bph.70254 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Pharmacology, 2026. Verfasst von Jelena Bešević und 11 weiteren Autor:innen. Beteiligte Einrichtung: Oxford Population Health (Nuffield Department of Population Health), University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Precision Medicine, Biological Specimen Banks, Drug Discovery. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Medical Research Council, Wellcome, British Heart Foundation, Cancer Research UK, National Institute for Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

UK Biobank is a large‐scale, prospective study with extensive genetic and phenotypic data on half a million individuals. Volunteers, aged between 40 and 69 years, were recruited between 2006 and 2010 from the general population of the United Kingdom. At recruitment, participants completed a series of questionnaires on a range of factors (including lifestyle and medical history), physical measurements were taken and biological samples were collected for long‐term storage. Large‐scale assays have been undertaken (including biochemical assays, genotyping, whole exome and whole genome sequencing, as well as proteomics and metabolomics) with potential for further assays to be performed on stored samples in the future. The participants provided consent for linkage to their health‐related records to identify health outcomes over time. The UK Biobank study, with its vast collection of genetic data, has enabled researchers worldwide to identify new drug targets for common diseases of middle and older age, and progress towards precision medicine. As the UK Biobank resource matures, its value to health‐related research will continue to grow. Thousands of researchers worldwide are actively using UK Biobank data to improve our understanding of the prevention, diagnosis and treatment of a wide range of diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineBiological Specimen BanksDrug DiscoveryHumansUnited KingdomMiddle AgedAgedAdultProspective StudiesUK Biobank

Stichwörter der Autor:innen

drug discoverymulti‐omics (genomics, proteomics, metabolomics)population‐based cohort studiesprecision medicinetranslational pharmacology

Autor:innen und Institutionen

  • Oxford Population Health (Nuffield Department of Population Health), University of Oxford, Oxford, UK.
  • UK Biobank, Greater Manchester, UK.
  • Human Genetics Centre of Excellence, Novo Nordisk Research Centre Oxford (NNRCO), Oxford, UK.
  • Neuroscience Data Science, Johnson & Johnson Innovative Medicine, Cambridge, Massachusetts, USA.
  • Division of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, University of Manchester, Manchester, UK.
  • Diabetes, Endocrinology and Metabolism Centre, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, NIHR Manchester Biomedical Research Centre, Manchester Academic Health Science Centre, Manchester, U…

ORCID-Profile: Ben Lacey

Förderung

  • UK Medical Research Council, Wellcome, British Heart Foundation, Cancer Research UK
  • National Institute for Health Research

Zitieren

APA

Bešević, J., Said, S., Nagy, R., Jamshidi, Y., Whelan, C. D., Carson, L., Rutter, M. K., Lewandowski, A. J., Effingham, M., Collins, R., Lacey, B., & Allen, N. E. (2026). UK Biobank: Transforming drug discovery and precision medicine. British Journal of Pharmacology. https://doi.org/10.1111/bph.70254

Vancouver

Bešević J, Said S, Nagy R, Jamshidi Y, Whelan CD, Carson L, et al. UK Biobank: Transforming drug discovery and precision medicine. British Journal of Pharmacology. 2026. doi:10.1111/bph.70254

BibTeX
@article{Beevi2026,
  author = {Bešević, Jelena and Said, Saredo and Nagy, Reka and Jamshidi, Yalda and Whelan, Christopher D and Carson, Lauren and Rutter, Martin K and Lewandowski, Adam J and Effingham, Mark and Collins, Rory and Lacey, Ben and Allen, Naomi E},
  title = {UK Biobank: Transforming drug discovery and precision medicine},
  journal = {British Journal of Pharmacology},
  year = {2026},
  doi = {10.1111/bph.70254}
}
Kostenlos starten →